Phase II trial of olaparib in combination with ceralasertib in patients with recurrent osteosarcoma.

Suzanne J. Forrest, Michael D. Kinnaman, J Andrew Livingston, Kieuhoa Tran Vo, Priscilla Merriam, Catherine Clinton, Kylene Desmith, Kerri Cavanaugh, Brunella Felicetti, Simon Smith, Emma Dean, Pei-Chi Kao, Wendy B. London, E. Alejandro Sweet-Cordero, Katherine A. Janeway. Phase II trial of olaparib in combination with ceralasertib in patients with recurrent osteosarcoma. Journal of Clinical Oncology. 2021 May 20; 39(15_suppl):tps11575-tps11575.

2021
https://researcherprofiles.org/profile/206692743

Suzanne J. Forrest, Michael D. Kinnaman, J Andrew Livingston, Kieuhoa Tran Vo, Priscilla Merriam, Catherine Clinton, Kylene Desmith, Kerri Cavanaugh, Brunella Felicetti, Simon Smith, Emma Dean, Pei-Chi Kao, Wendy B. London, E. Alejandro Sweet-Cordero, Katherine A. Janeway